Plasminogen Activator Inhibitor Type-1 Tag Single-Nucleotide Polymorphisms in Patients with Diabetes Mellitus Type 2 and Diabetic Retinopathy

References

• Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010;376(9735):124–136.
   PubMed Web of Science ®Google Scholar
• Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 2007;14(4):179–183.
   PubMed Web of Science ®Google Scholar
• Zeng J, Chen B. Epigenetic mechanisms in the pathogenesis of diabetic retinopathy. Ophthalmologica 2014;232(1):1–9.
   PubMed Web of Science ®Google Scholar
• Zhong ZL, Chen S. Plasma plasminogen activator inhibitor-1 is associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population. Exp Diabetes Res 2012;2012:350852.
   PubMedGoogle Scholar
• Nittala MG, Keane PA, Zhang K, Sadda SR. Risk factors for proliferative diabetic retinopathy in a Latino American population. Retina 2014;34(8):1594–1599.
   PubMed Web of Science ®Google Scholar
• Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, 3rd, et al. Diabetic retinopathy. Diabetes Care 1998;21(1):143–156.
   PubMed Web of Science ®Google Scholar
• Henricsson M, Nystrom L, Blohme G, Ostman J, Kullberg C, Svensson M, et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based diabetes incidence study in Sweden (DISS). Diabetes Care 2003;26(2):349–354.
   PubMed Web of Science ®Google Scholar
• Cho H, Sobrin L. Genetics of diabetic retinopathy. Curr Diab Rep 2014;14(8):515.
   PubMed Web of Science ®Google Scholar
• Lipner EM, Tomer Y, Noble JA, Monti MC, Lonsdale JT, Corso B, et al. Linkage analysis of genomic regions contributing to the expression of type 1 diabetes microvascular complications and interaction with HLA. J Diabetes Res 2015;2015:694107.
   PubMed Web of Science ®Google Scholar
• Monti MC, Lonsdale JT, Montomoli C, Montross R, Schlag E, Greenberg DA. Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes. J Clin Endocrinol Metab 2007;92(12):4650–4655.
   PubMed Web of Science ®Google Scholar
• Billings LK, Florez JC. The genetics of type 2 diabetes: what have we learned from GWAS? Ann N Y Acad Sci 2010;1212:59–77.
   PubMed Web of Science ®Google Scholar
• Kuo JZ, Wong TY, Rotter JI. Challenges in elucidating the genetics of diabetic retinopathy. JAMA Ophthalmol 2014;132(1):96–107.
   PubMed Web of Science ®Google Scholar
• Castellino FJ, Ploplis VA. Structure and function of the plasminogen/plasmin system. Thromb Haemost 2005;93(4):647–654.
   PubMed Web of Science ®Google Scholar
• Erem C, Hacihasanoglu A, Celik S, Ovali E, Ersoz HO, Ukinc K, et al. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications. Med Princ Pract 2005;14(1):22–30.
   PubMed Web of Science ®Google Scholar
• Ezzidi I, Mtiraoui N, Chaieb M, Kacem M, Mahjoub T, Almawi WY. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients. Diabetes Metab 2009;35(3):214–219.
   PubMed Web of Science ®Google Scholar
• Grant MB, Spoerri PE, Player DW, Bush DM, Ellis EA, Caballero S, et al. Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice. Invest Ophthalmol Vis Sci 2000;41(8):2296–2302.
   PubMed Web of Science ®Google Scholar
• Mansfield MW, Stickland MH, Carter AM, Grant PJ. Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, and in patients with diabetic retinopathy. Thromb Haemost 1994;71(6):731–736.
   PubMed Web of Science ®Google Scholar
• Xu K, Liu X, Yang F, Cui D, Shi Y, Shen C, et al. PAI-1-675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study. PLoS One 2013;8(11):e79150.
   PubMed Web of Science ®Google Scholar
• Zhang T, Pang C, Li N, Zhou E, Zhao K. Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis. BMC Med 2013;11:1.
   PubMed Web of Science ®Google Scholar
• Eriksson P, Kallin B, van ‘t Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995;92(6):1851–1855.
   Google Scholar
• Tachmitzi SV, Tsironi EE, Kotoula MG, Dardiotis E, Elefteriadis T, Chatzoulis DZ, et al. Αssociation between polymorphisms and haplotypes in AKR1B1 and diabetes type 2 leading to complications. Int J Med Health Sci 2015;4(4):430–436.
   Google Scholar
• Stefanidis I, Kytoudis K, Papathanasiou AA, Zaragotas D, Melistas L, Kitsios GD, et al. XbaI GLUT1 gene polymorphism and the risk of type 2 diabetes with nephropathy. Dis Markers 2009;27(1):29–35.
   PubMed Web of Science ®Google Scholar
• Dardiotis E, Paterakis K, Siokas V, Tsivgoulis G, Dardioti M, Grigoriadis S, et al. Effect of angiotensin-converting enzyme tag single nucleotide polymorphisms on the outcome of patients with traumatic brain injury. Pharmacogenet Genomics 2015;25(10):485–490.
   PubMed Web of Science ®Google Scholar
• Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002;296(5576):2225–2229.
   PubMed Web of Science ®Google Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21(2):263–265.
   PubMed Web of Science ®Google Scholar
• Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006;38(2):209–213.
   PubMed Web of Science ®Google Scholar
• Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006;22(15):1928–1929.
   PubMed Web of Science ®Google Scholar
• Lettre G, Lange C, Hirschhorn JN. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet Epidemiol 2007;31(4):358–362.
   PubMed Web of Science ®Google Scholar
• Zintzaras E. The generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies. Stat Appl Genet Mol Biol 2010;9: Article21.
   PubMed Web of Science ®Google Scholar
• Zintzaras E. The power of generalized odds ratio in assessing association in genetic studies with known mode of inheritance. J Appl Stat 2012;39(12):2569–2581.
   Web of Science ®Google Scholar
• Ziegler A, Van Steen K, Wellek S. Investigating Hardy-Weinberg equilibrium in case-control or cohort studies or meta-analysis. Breast Cancer Res Treat 2011;128(1):197–201.
   PubMed Web of Science ®Google Scholar
• Dobrovolsky AB, Titaeva EV. The fibrinolysis system: regulation of activity and physiologic functions of its main components. Biochemistry (Mosc) 2002;67(1):99–108.
   PubMed Web of Science ®Google Scholar
• Zorio E, Gilabert-Estelles J, Espana F, Ramon LA, Cosin R, Estelles A. Fibrinolysis: the key to new pathogenetic mechanisms. Curr Med Chem 2008;15(9):923–929.
   PubMed Web of Science ®Google Scholar
• Cale JM, Lawrence DA. Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agent. Curr Drug Targets 2007;8(9):971–981.
   PubMed Web of Science ®Google Scholar
• Vaughan DE. PAI-1 antagonists: the promise and the peril. Trans Am Clin Climatol Assoc 2011;122:312–325.
   PubMedGoogle Scholar
• Grassi MA, Tikhomirov A, Ramalingam S, Below JE, Cox NJ, Nicolae DL. Genome-wide meta-analysis for severe diabetic retinopathy. Hum Mol Genet 2011;20(12):2472–2481.
   PubMed Web of Science ®Google Scholar
• Huang YC, Lin JM, Lin HJ, Chen CC, Chen SY, Tsai CH, et al. Genome-wide association study of diabetic retinopathy in a Taiwanese population. Ophthalmology 2011;118(4):642–648.
   PubMed Web of Science ®Google Scholar
• Sheu WH, Kuo JZ, Lee IT, Hung YJ, Lee WJ, Tsai HY, et al. Genome-wide association study in a Chinese population with diabetic retinopathy. Hum Mol Genet 2013;22(15):3165–3173.
   PubMed Web of Science ®Google Scholar
• Fu YP, Hallman DM, Gonzalez VH, Klein BE, Klein R, Hayes MG, et al. Identification of diabetic retinopathy genes through a genome-wide association study among Mexican-Americans from Starr County, Texas. J Ophthalmol 2010; 2010.
   Google Scholar
• Simo-Servat O, Hernandez C, Simo R. Genetics in diabetic retinopathy: current concepts and new insights. Curr Genomics 2013;14(5):289–299.
   PubMed Web of Science ®Google Scholar
• Hosseini SM, Boright AP, Sun L, Canty AJ, Bull SB, Klein BE, et al. The association of previously reported polymorphisms for microvascular complications in a meta-analysis of diabetic retinopathy. Hum Genet 2015;134(2):247–257.
   PubMed Web of Science ®Google Scholar
• Kimura H, Gejyo F, Suzuki Y, Suzuki S, Miyazaki R, Arakawa M. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1. Kidney Int 1998;54(5):1659–1669.
   PubMed Web of Science ®Google Scholar